ARPHA OAI-PMH Endpointmetadata only
Post-treatment serum interleukin-6 is independently associated with disease progression in patients with advanced non-small cell lung cancer and coexisting COPD: a multicenter real-world cohort study
biomarker, chemotherapy, copd, immunotherapy, interleukin-6, nsclc, post-treatment
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 673302
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.